Latest Insider Transactions at Rapt Therapeutics, Inc. (RAPT)
This section provides a real-time view of insider transactions for Rapt Therapeutics, Inc. (RAPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RAPT Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RAPT Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2020
|
Kleiner Perkins Caufield & Byers Xv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
650,000
-20.02%
|
-
|
|
Aug 17
2020
|
Column Group Ii, LP |
SELL
Open market or private sale
|
Direct |
538,654
-10.81%
|
$11,850,388
$22.75 P/Share
|
|
Jul 14
2020
|
Kleiner Perkins Caufield & Byers Xv, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
300,000
-8.46%
|
-
|
|
Nov 04
2019
|
Column Group Ii, LP |
BUY
Conversion of derivative security
|
Direct |
6,102,151
+32.83%
|
-
|
|
Nov 04
2019
|
Column Group Ii, LP |
BUY
Open market or private purchase
|
Direct |
625,000
+11.15%
|
$7,500,000
$12.0 P/Share
|
|
Nov 04
2019
|
Kleiner Perkins Caufield & Byers Xv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,547,063
+17.2%
|
-
|